Accelovance, Inc. announces acquisition of Altair Clinical, Ltd., a full service European clinical CRO and provider of global clinical CRO resourcing solutions to pharmaceutical, biotech, and medical device companies. To learn more, click on the link for Press Release.
Are you working on an Early Phase Oncology protocol or study concept? Participate in the Accelovance Oncology Protocol Challenge!
Accelovance's Protocol Challenge is an opportunity for a confidential review and discussion of your protocol or concept document. Our experts will review your information and provide a summary of operational, therapeutic, and strategic considerations tailored to your protocol/study concept. This assessment is free of charge, with no obligation of future work. To learn more, click on the link to download an overview of Accelovance's Protocol Challenge as well as information on how to participate.
November 9, 2015 – November 11, 2015 – Madrid, Spain